Page last updated: 2024-11-06

triethylenemelamine and Lupus Erythematosus, Systemic

triethylenemelamine has been researched along with Lupus Erythematosus, Systemic in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROHN, RJ1
BOND, WH1
BRODY, JI1
BEIZER, LH1

Other Studies

2 other studies available for triethylenemelamine and Lupus Erythematosus, Systemic

ArticleYear
Some effects of nitrogen mustard and triethylene melamine in acute disseminated lupus erythematosus.
    The American journal of the medical sciences, 1953, Volume: 226, Issue:2

    Topics: Humans; Lupus Erythematosus, Systemic; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelam

1953
ALTERATION OF BLOOD GROUP ANTIGENS IN LEUKEMIC LYMPHOCYTES.
    The Journal of clinical investigation, 1965, Volume: 44

    Topics: ABO Blood-Group System; Anemia; Anemia, Aplastic; Antigens; Blood Group Antigens; Child; Chlorambuci

1965